Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications.
about
Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters.Tissue engineering of urinary bladder - current state of art and future perspectives.New malignancies following cancer of the urinary bladder: analysis of German cancer registry data.Pulmonary tumor thrombotic microangiopathy induced by ureteral carcinoma: a necropsy case report.Five cases report of solid tumor synchronously with hematologic malignancy.M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.Development and progression of urothelial carcinoma.Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.Bladder cancer following upper tract urothelial carcinoma.Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.Bladder cancer: clinical and pathological profile.Tissue engineering for the oncologic urinary bladder.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.The effect of multiple primary rules on cancer incidence rates and trends.Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma.Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma.IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development
P2860
Q28084159-97B25E0D-4FE8-4663-AB86-905D333D48DFQ30403508-AA339FC1-02C3-4386-B277-F42EF4FD45AFQ30442568-00FA06B5-9E85-4F45-A6BA-A84F68C642DDQ34094610-D8FEBA45-10F1-4CCA-852E-23E97B8C9307Q34259382-0655D921-85C1-402B-B719-1149C9478BDEQ35877770-2623B727-E4D7-4AA6-A1EB-E8A84407C314Q36212836-4DA156C6-6999-4EE2-A946-2D8116E63E9BQ36527765-4AF06185-BD29-46A2-898C-2CE38193BBD0Q36663570-94A9DEED-7A0A-4495-83E6-CFA1FC076966Q37038905-242D3516-C316-431B-9EDF-A6ADC7115CF7Q37152820-36E7FA20-8636-4839-9DD1-B7A703C1AA85Q37278983-FD07FB2D-1BCD-4097-BA1A-BE527E28214AQ38036123-6A27B387-6FD0-433A-93BA-BBCF5A86F82BQ38297729-6D1F2D7C-B70F-4A78-B38D-C37828AA565BQ38613417-D405A6DE-F005-4DB8-B880-AC4AFE8BEC66Q38801627-FD99D845-796D-4773-A7DE-14643D8A99C0Q39585197-7BD396FE-C1AE-4F71-ACE3-FCC2704BCC32Q42105949-42ABE17C-236E-4D70-98F3-C4B4BAAC4E71Q47777493-C0889DBD-D6E5-4A41-B93D-B9F996D22A71Q51749500-94C81B34-0DBF-42EC-BBC8-FB414B91052BQ52629158-0BA32CC9-11E2-498C-8EE9-77C83BFF6E81Q55038654-F7336E0D-2986-476C-AA18-8781C37992D7Q55044981-111E1633-0CE3-48C9-AA27-800BADBE160BQ58835463-049EDD4B-2449-4579-A9F4-F3626457415B
P2860
Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Origin of multifocal carcinoma ...... sis and clinical implications.
@ast
Origin of multifocal carcinoma ...... sis and clinical implications.
@en
Origin of multifocal carcinoma ...... sis and clinical implications.
@nl
type
label
Origin of multifocal carcinoma ...... sis and clinical implications.
@ast
Origin of multifocal carcinoma ...... sis and clinical implications.
@en
Origin of multifocal carcinoma ...... sis and clinical implications.
@nl
prefLabel
Origin of multifocal carcinoma ...... sis and clinical implications.
@ast
Origin of multifocal carcinoma ...... sis and clinical implications.
@en
Origin of multifocal carcinoma ...... sis and clinical implications.
@nl
P2860
P1476
Origin of multifocal carcinoma ...... sis and clinical implications.
@en
P2093
Tomonori Habuchi
P2860
P304
P356
10.1111/J.1442-2042.2005.01155.X
P577
2005-08-01T00:00:00Z